AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 68(4), 2003, pp. 453-455
Copyright © 2003 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TARR, P. E.
Right arrow Articles by LUCEY, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TARR, P. E.
Right arrow Articles by LUCEY, D. R.
Related Collections
Right arrow Strongyloidiasis

CASE REPORT: RECTAL ADMINSTRATION OF IVERMECTIN TO A PATIENT WITH STRONGYLOIDES HYPERINFECTION SYNDROME

PHILIP E. TARR*, PETER S. MIELE*, KENNETH S. PEREGOY, MARGO A. SMITH, FRANKLIN A. NEVA, AND DANIEL R. LUCEY
Section of Infectious Diseases, Department of Medicine, and Department of Pharmacy, Washington Hospital Center, Washington, District of Columbia; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

 

ABSTRACT

Strongyloides hyperinfection syndrome may be complicated by paralytic ileus that interferes with the absorption of oral anti-helminthics. We report on the administration of ivermectin as a rectal enema preparation to a renal transplant recipient with Strongyloides hyperinfection syndrome and progressive ileus. Attempts at treatment using nasogastric albendazole and ivermectin were unsuccessful despite clamping the nasogastric tube after drug administration. Ivermectin tablets were ground to a powder, resuspended in a commercially available suspending agent, and administered per rectum. The suspending agent was chosen for its near-physiologic osmolality to allow longer retention, in contrast to many enema preparations that have a laxative effect. The patient improved markedly within 72 hours of initiation of the therapy per rectum and recovered fully. Ivermectin administered as an enema may be beneficial in patients with severe strongyloidiasis who are unable to absorb or tolerate oral therapy.

Received September 20, 2002. Accepted for publication November 6, 2002.

Acknowledgments: We are grateful to Drs. Timothy Light, Jimmy Light, Thomas C. Jones, and Nancy Pietroski for helpful discussions.

Authors’ addresses: Philip E. Tarr, Peter S. Miele, Margo A. Smith, and Daniel R. Lucey, Section of Infectious Diseases, Washington Hospital Center, Room 2A-56, 110 Irving Street NW, Washington, DC 20010. Kenneth S. Peregoy, Department of Pharmacy, Washington Hospital Center, 110 Irving Street NW, Washington, DC 20010. Franklin A. Neva, Laboratory of Parasitic Diseases, Building 4, Room B1-27, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

Reprint requests: Philip E. Tarr, Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland, Telephone: 41-21-314-1010, Fax: 41-21-314-1018, E-mail: philiptarr{at}yahoo.com

* These authors contributed equally to this publication.




This article has been cited by other articles:


Home page
 J Intensive Care MedHome page
V. K. Agarwal, H. S. Khurana, H. X. Le, G. Mathisen, and N. Kamangar
30-Year-old HIV-positive Female With Diffuse Alveolar Hemorrhage
J Intensive Care Med, May 1, 2009; 24(3): 200 - 204.
[Abstract] [PDF]

Home page
 Am J Trop Med HygHome page
V. Leung, G. N. Al-Rawahi, J. Grant, L. Fleckenstein, and W. Bowie
Failure of Subcutaneous Ivermectin in Treating Strongyloides Hyperinfection
Am J Trop Med Hyg, December 1, 2008; 79(6): 853 - 855.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
S. A. TURNER, J. D. MACLEAN, L. FLECKENSTEIN, and C. GREENAWAY
PARENTERAL ADMINISTRATION OF IVERMECTIN IN A PATIENT WITH DISSEMINATED STRONGYLOIDIASIS
Am J Trop Med Hyg, November 1, 2005; 73(5): 911 - 914.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. PACANOWSKI, M. D. SANTOS, A. ROUX, C. LE MAIGNAN, J. GUILLOT, V. LAVARDE, and M. CORNET
SUBCUTANEOUS IVERMECTIN AS A SAFE SALVAGE THERAPY IN STRONGYLOIDES STERCORALIS HYPERINFECTION SYNDROME: A CASE REPORT
Am J Trop Med Hyg, July 1, 2005; 73(1): 122 - 124.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society of Tropical Medicine and Hygiene.